Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 1369 of 6351
-
New therapy combo aims to keep women in opioid recovery
Disease control Recruiting nowUsing a hybrid type 1 effectiveness-implementation approach, this study aims to evaluate the impact of a novel stepped care model ("PCT+2HOPE") versus treatment as usual (TAU) on increasing retention in community-based medication for opioid use disorder (MOUD) treatment among wom…
Sponsor: Yale University • Aim: Disease control
Last updated Jul 18, 2026 00:00 UTC
-
Steroid showdown: can prednisolone save lungs in rare fibrotic disease?
Disease control Not yet recruitingHypersensitivity Pneumonitis (HP) is an immune-mediated disease that manifests as interstitial lung disease after exposure to an inhaled antigen, often unidentified. HP can be classified as non-fibrotic or fibrotic HP. Fibrotic HP is associated with impaired quality of life (QoL)…
Phase 3 • Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Disease control
Last updated Jun 27, 2026 07:53 UTC
-
Could a higher drug dose help sickle cell patients get stem cell transplants?
Disease control Not yet recruitingThe objective of this study is to demonstrate whether high-dose plerixafor can effectively mobilize hematopoietic stem cells in patients with sickle cell disease. It will also learn about the safety of this drug in higher doses in these patients. The main questions it aims to ans…
Phase 1/2 • Sponsor: Hospital Israelita Albert Einstein • Aim: Disease control
Last updated Jun 27, 2026 08:11 UTC
-
New prostate cancer radiation cuts sessions in half
Disease control Not yet recruitingThis is a single-arm, exploratory phase I clinical trial evaluating the safety and efficacy of ultra-hypofractionated carbon ion radiotherapy (CIRT) in 6 fractions compared to the conventional 12-fraction regimen in patients with low- and intermediate-risk localized prostate canc…
Phase 1 • Sponsor: Yonsei University • Aim: Disease control
Last updated Jun 27, 2026 12:36 UTC
-
Personalized blood pressure after stroke could boost recovery
Disease control Not yet recruitingThe RESCUE-BP is a multi-centered, prospective, randomized, open label, blinded endpoint (PROBE) phase III trial. In patients with acute ischemic stroke who have undergone endovascular treatment and achieved successful recanalization, the evaluation will compare a stratified bloo…
Phase 3 • Sponsor: Beijing Tiantan Hospital • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC
-
Heart shunt device aims to boost energy in failing hearts
Disease control Not yet recruitingThis prospective, single-center post-market-follow-up study aims to fill knowledge gaps by combining advanced cardiac MRI/MRS with systemic mitochondrial assays and exercise testing to characterize the energetic and functional impact of IASD therapy in HFrEF patients.
Sponsor: Heinrich-Heine University, Duesseldorf • Aim: Disease control
Last updated Jun 27, 2026 12:24 UTC
-
New wearable device aims to unfreeze Parkinson's patients in their tracks
Symptom relief Not yet recruitingThe goal of this clinical trial is to learn if the ParkinSense system, a customizable, multimodal, and adaptable cueing system, can assist with freezing of gait (FOG) in patients with Parkinson's disease. The main question it aims to answer is: is the percent of time spent frozen…
Sponsor: Barron Associates, Inc. • Aim: Symptom relief
Last updated Jun 27, 2026 12:23 UTC
-
Gene therapy takes on rare eye disease in Second-Eye trial
Disease control Not yet recruitingThis is a multi-centre, single- arm, non-randomized, open-label phase 1/2 clinical trial which enables dosing of the fellow eyes of patients who received VGR-R01 administration in previous studies.
Phase 1/2 • Sponsor: Shanghai Vitalgen BioPharma Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 12:34 UTC
-
Should surgeons remove the primary tumor in metastatic breast cancer? new study aims to find out.
Disease control By invitation onlyBreast cancer is the most common malignancy in women, with stage IV disease at diagnosis in 5-10% of cases. Oligometastatic breast cancer (OMBC), defined as limited metastases (≤3-5 in ≤1-2 organs), may have better outcomes. Systemic therapy is the cornerstone of treatment, while…
Sponsor: Sharif Medical Research Center • Aim: Disease control
Last updated Jun 27, 2026 12:35 UTC
-
New scan aims to spot liver cancer more clearly
Diagnosis Not yet recruitingThis is a prospective, single-center, single-arm, phase I/II study designed to evaluate (1) the safety, tolerability, and imaging characteristics of 68Ga-NYM207 (Phase A), and (2) the diagnostic performance of 68Ga-NYM207 in detecting hepatocellular carcinoma (HCC) (Phase B). Thi…
Phase 1/2 • Sponsor: Peking Union Medical College Hospital • Aim: Diagnosis
Last updated Jun 27, 2026 12:33 UTC
-
Can an ancient herbal remedy tame rheumatoid arthritis?
Disease control Recruiting nowRheumatoid Arthritis (RA) is a chronic disease characterised by symmetric, polyarticular pain and swelling, involving small joints of the hands and feet. RA can lead to irreversible joint damage without treatment, causing disability and impacting daily activities and work product…
Phase 2/3 • Sponsor: Singapore General Hospital • Aim: Disease control
Last updated Aug 19, 2026 00:00 UTC
-
New shot aims to reverse liver scarring in MASH patients
Disease control Not yet recruitingThis is a Phase II, multicenter, randomized, double-blind, placebo-controlled, parallel-design clinical trial to evaluate efficacy and safety of QL2401 in patients with metabolic dysfunction-associated steatohepatitis and liver fibrosis (F2-F3).
Phase 2 • Sponsor: Qilu Pharmaceutical Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC
-
Immune cells take on nerve tumors: new trial launches
Disease control Stopped earlyThe primary objective of this study is to verify the safety of antigen-specific T cells (CAR-T) and engineered immune effector cytotoxic T cells (EIE) modified by immunoregulatory genes and immune modified dendritic cell vaccine (DCvac) in the treatment of neurofibromatosis or sc…
Phase 1/2 • Sponsor: Shenzhen Geno-Immune Medical Institute • Aim: Disease control
Last updated Aug 26, 2026 00:00 UTC
-
Gum disease gel could save your teeth
Disease control Not yet recruitingChronic periodontitis is one of the most prevalent inflammatory diseases affecting the tooth-supporting structures and is characterized by progressive clinical attachment loss and alveolar bone resorption resulting from a complex interaction between pathogenic microorganisms and …
Phase 4 • Sponsor: Fayoum University • Aim: Disease control
Last updated Jun 27, 2026 13:05 UTC
-
New PET scan tracer aims to spot blood cancers more clearly
Diagnosis Recruiting nowThe goal of this clinical trial is to evaluate the biodistribution, radiation dosimetry, safety, and time-dependent image quality of \^68\^Ga-EV203 injection in patients with hematological malignancies (multiple myeloma, non-Hodgkin lymphoma, or acute myeloid leukaemia), aged 18-…
Sponsor: Zhejiang Cancer Hospital • Aim: Diagnosis
Last updated Jun 28, 2026 00:00 UTC
-
Blood clue may predict brain fog after surgery in seniors
Knowledge-focused Not yet recruitingThe term perioperative neurocognitive disorders (PND) is derived from postoperative cognitive dysfunction (POCD), and has been renamed as PND in recent years in accordance with the latest international consensus. PND specifically refers to changes in mental, social and cognitive …
Sponsor: Nanjing First Hospital, Nanjing Medical University • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:00 UTC
-
New pain block cocktail may cut opioid use after breast surgery
Symptom relief OngoingA large number of patients undergoing major surgical procedures for the management of breast cancer complain of acute and chronic postoperative pain. Morphine administration for acute pain after mastectomy surgery has many side effects. Regional block techniques, such as paravert…
Sponsor: Zagazig University • Aim: Symptom relief
Last updated Aug 26, 2026 00:00 UTC
-
Could a tiny ear device ease severe PMS and menopause symptoms?
Symptom relief Recruiting nowTranscutaneous Auricular Neurostimulation (tAN) will be administered to women with premenstrual syndrome (PMS), premenstrual dysphoric disorder (PMDD), and perimenopause. The investigators will examine whether tAN improves symptomology by collecting self-report data before the in…
Sponsor: Texas Christian University • Aim: Symptom relief
Last updated Jul 09, 2026 00:00 UTC
-
Can a laser beam silence stubborn hip pain?
Symptom relief Recruiting nowGreater Trochanteric Pain Syndrome (GTPS) is a common cause of lateral hip pain that can significantly impair daily activities and quality of life. Conservative treatments, including physical therapy modalities and injections, are considered first-line management. High-Intensity…
Sponsor: Ankara Etlik City Hospital • Aim: Symptom relief
Last updated Aug 08, 2026 00:03 UTC
-
Could a simple fibre supplement reshape your gut microbiome?
Disease control OngoingThis study will evaluate the effects of the Artah Essential Fibre+ supplement on the microbiome and gut health over an 8-week period. The study is a single-arm, unblinded virtual trial enrolling 50 participants who will consume the test product daily and complete questionnaires a…
Sponsor: Artah Nutrition Limited • Aim: Disease control
Last updated Aug 26, 2026 00:00 UTC